Supergenics Share Price

Equities

SGBHD

MYL03033O007

Construction & Engineering

End-of-day quote BURSA MALAYSIA 23:00:00 10/03/2024 GMT 5-day change 1st Jan Change
0.5 MYR -1.96% Intraday chart for Supergenics -.--% +117.39%

Financials

Sales 2021 10.99M 2.32M 185M Sales 2022 10.72M 2.26M 180M Capitalization 27.44M 5.79M 461M
Net income 2021 - 0 0 Net income 2022 - 0 0 EV / Sales 2021 2.69 x
Net Debt 2021 3.51M 741K 59.07M Net Debt 2022 4.68M 989K 78.78M EV / Sales 2022 3 x
P/E ratio 2021
1,284 x
P/E ratio 2022
79.3 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 28.56%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.96%
3 months+117.39%
6 months+117.39%
Current year+117.39%
More quotes
Current year
0.31
Extreme 0.31
0.51
1 year
0.22
Extreme 0.22
0.51
3 years
0.22
Extreme 0.22
0.51
5 years
0.22
Extreme 0.22
0.51
10 years
0.22
Extreme 0.22
0.51
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 23/04/19
Corporate Secretary - 01/06/22
Members of the board TitleAgeSince
Director/Board Member 59 23/04/19
Chief Executive Officer 46 23/04/19
Director/Board Member 44 27/01/22
More insiders
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated turnkey solutions, Biomedical and Investment holding. The Company is engaged in the provision of integrated turnkey solutions for the related development of cleanroom and the provision of related maintenance services. The Biomedical segment is engaged in the provision of administrative health care services and operating of medical laboratories and developing of medical treatment and wellness products. The Company provides facility planning, designing, constructing, installing, validating, monitoring and maintaining cleanrooms in order to create an indoor environment suitable for activities which require a certain air quality. Its subsidiaries include Supergenics Solution Sdn Bhd, Supergenics Life Science Sdn Bhd and Supergenics Therapeutic Sdn Bhd.
More about the company